The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
HH&L ACQUISITION CO *W EXP 02/04/202 G39714129   8,000 400,000 SH   SOLE   400,000 0 0
TAIWAN SEMICONDUCTOR MFG LTD SPONSORED ADS 874039100   3,999,964 39,635 SH   SOLE   39,635 0 0
YS BIOPHARMA CO LTD *W EXP 03/15/202 G9845F117   35,250 750,000 SH   SOLE   750,000 0 0
YS BIOPHARMA CO LTD ORDINARY SHARES G9845F109   2,217,902 1,607,175 SH   SOLE   1,607,175 0 0